Back

Prognostic value of reticulocyte production ability in patients with chronic heart failure

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Models to predict unfavourable outcomes in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Motoki Nakao

Hokkaido University, Sapporo (Japan)

8 More presentations in this session

Presentation thumbnail
Risk prediction models for incident heart failure: a systematic review and meta-analysis
Mr J. Navarro (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
A flexible, calibrated transformer-based risk model for prediction of clinical outcomes in patients with heart failure; an open cohort study using linked UK EHR
Doctor S. Rao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Explainable machine learning and multi-modal data for predicting readmission in patients with heart failure
Ms R. Chae (US)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis
Doctor V. Anastasiou (London, GB)
Abstract Slides Video
Presentation thumbnail
Development and validation of a predicting model for risk of mortality in heart failure patients with mildly reduced ejection fraction post discharge
Professor Y. Zhu (Xiangtan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Models to predict unfavourable outcomes in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impact of anemia on the evolution of hospitalized HFpEF patients
thumbnail
Congress Presentation
Anemia and sideropenia in patients with decompensated heart failure
thumbnail
Congress Presentation
Perennial parameter in intravenous iron therapy for heart failure: reticulocyte crisis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources